Risk of IBD in IBS patients

Irritable bowel syndrome (IBS) is linked to an increased long-term risk of developing inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD). A large study using UK Biobank data followed 447,631 participants for over 14 years and found that individuals with IBS had a significantly higher chance of developing IBD. Specifically, IBS patients had a 68% higher risk of any IBD, with a 60% increased risk for UC and a 104% higher risk for CD. This elevated risk persisted even after 10 years.

The study also analyzed 76,992 participants through a digestive health questionnaire and found that IBS patients had a higher prevalence of IBD. Among IBS subtypes, diarrhea-predominant IBS (IBS-D) showed the strongest link to IBD, with a 3.72 times higher likelihood of having IBD, suggesting a closer connection between IBS-D and inflammatory conditions.

These findings suggest that IBS and IBD may share overlapping mechanisms. Clinically, IBS patients, especially those with persistent symptoms or IBS-D, should be monitored closely for signs of IBD. Early detection and treatment of inflammatory changes could improve outcomes and provide better disease management for these patients.